Werner's syndrome (WS) is an autosomal recessive disorder, characterized at the cellular level by genomic instability in the form of variegated translocation mosaicism and extensive deletions. Individuals with WS prematurely develop multiple age-related pathologies and exhibit increased incidence of cancer. WRN, the gene defective in WS, encodes a 160-kDa protein (WRN), which has 3 0 -5 0 exonuclease, DNA helicase and DNAdependent ATPase activities. WRN-defective cells are hypersensitive to certain genotoxic agents that cause replication arrest and/or double-strand breaks at the replication fork, suggesting a pivotal role for WRN in the protection of the integrity of the genoma during the DNA replication process. Here, we show that WRN is phosphorylated through an ATR/ATM dependent pathway in response to replication blockage. However, we provide evidence that WRN phosphorylation is not essential for its subnuclear relocalization after replication arrest. Finally, we show that WRN and ATR colocalize after replication fork arrest, suggesting that WRN and the ATR kinase collaborate to prevent genome instability during the S phase.
Introduction
Werner's syndrome (WS) is an autosomal recessive disorder, characterized at the cellular level by genomic instability in the form of variegated translocation mosaicism and extensive deletions (Salk et al., 1981; Salk, 1985; Fukuchi et al., 1989) . Individuals with WS prematurely develop multiple age-related pathologies including bilateral cataracts, greying of the hair, wrinkled skin, osteoporosis, type II diabetes, atherosclerosis and increased incidence of cancer (reviewed in Mohaghegh and Hickson, 2001) . WRN, the gene defective in WS, encodes a 160-kDa protein (WRN), which has 3 0 -5 0 exonuclease, DNA helicase and DNAdependent ATPase activities (Gray et al., 1997; Huang et al., 1998; Kamath-Loeb et al., 1998; Shen et al., 1998) . WRN has been reported to interact with p53, replication protein A (RPA), proliferating cell nuclear antigen (PCNA), DNA polymerase d, and to associate with the DNA replication complex (reviewed in Brosh and Bohr, 2002) . It has also been shown that WRN interacts with Ku and DNA-PK and colocalizes with the RAD51 recombinase, suggesting a function in DNA repair/ recombination pathways (Cooper et al., 2000; Li and Comai, 2000; Orren et al., 2001; Sakamoto et al., 2001; Yannone et al., 2001 ). In addition, WS cells are hypersensitive to certain genotoxic agents that cause replication arrest and/or DSBs at the replication fork (Pichierri et al., 2000a,b; Poot et al., 1992 Poot et al., , 1999 Poot et al., , 2001 , suggesting a pivotal role for WRN to protect the integrity of the genome during the DNA replication process (Frei and Gasser, 2000) . This is further supported by our recent studies indicating that WRN is required for a fruitful recovery from replication blockage or S-phase-associated DNA damage (Pichierri et al., 2001) . However, the precise role for WRN in genome integrity as well as its response to replication stress are yet unknown. One of the most common modifications in proteins involved in the response to genotoxic or replicative stress is phosphorylation. Among the enzymes phosphorylated during the DNA-damage response is also BLM (Ababou et al., 2000 (Ababou et al., , 2002 Franchitto and Pichierri, 2002) , which is a member of the RecQ class of helicase, as WRN. Moreover, consensus sequences for ATM and ATR have been localized in WRN (Kim et al., 1999) . Thus, we sought to determine in vivo whether WRN protein could undergo phosphorylation as a consequence of replication fork stall or replicationassociated DNA damage. We show that WRN is specifically phosphorylated after replication-perturbing treatments in a manner that is both ATR-and ATMdependent. We also demonstrate that WRN phosphorylation and its subnuclear localization are independent events and that, after replication fork arrest or DNA damage induced in the S phase, the ATR kinase and WRN colocalize. Our results suggest a novel mechanism by which WRN could respond to replication stress indicative of WRN and ATR cooperation in preventing genome instability during the S phase.
Results
WRN protein is specifically phosphorylated in response to DNA damage resulting in replication fork blockage It has been previously reported that WS cells are extremely sensitive to agents that result in replication fork blockage (Pichierri et al., 2000a,b; Poot et al., 1999 Poot et al., , 2001 , and that WRN seems to be essential for the correct recovery from replication arrest (Pichierri et al., 2001) .
It is known that several proteins involved in the response to replication stress, such as the CHK1 and 2 kinases, BRCA1 and RPA, undergo phosphorylation to modulate their own activity (Zernik-Kobak et al., 1997; Tibbetts et al., 2000; Shiloh, 2001; Wang et al., 2001 ), thus we sought to analyse whether WRN could be modified in response to agents that cause replication arrest.
We exposed normal human lymphoblasts, fibroblasts and HeLa cells to 2 mm hydroxyurea (HU), different doses of camptothecin (CPT) for 2 h, or UVC, and 4 h later we examined WRN protein status by Western blot. We found that in treated samples, WRN migrated slower than in controls (Figure 1a ). WRN phosphorylation level did not increase with dose, at least at the doses used ( Figure 1a) . In HU-treated cells, the slower migrating form of WRN was detected starting from 1 h up to 12 h, but it was no more detectable at 18 h, suggesting that WRN modification rapidly occurs in response to replication fork arrest induced by HU treatment (Figure 1b) . In contrast, WRN modification appeared time-dependent after both CPT and UVC treatments. After CPT, both the unmodified and modified WRN forms were detectable at 1 h, whereas after UVC, the faster migrating form of WRN was present up to 2 h (Figure 1b) . Interestingly, conversion of WRN into its slower migrating form corresponded roughly of the complete inhibition of DNA synthesis, irrespective of the treatment. In fact, HU-induced replication arrest was clearly evident already at 1 h, whereas after CPT or UVC, it was noticeable only starting at 2 and 4 h, respectively (Figure 2 ).
To verify if the appearance of the slower migrating form following replication arrest could be because of specific phosphorylation, WCEs prepared from HeLa cells either untreated or exposed to HU or CPT were immunoprecipitated using anti-WRN antibodies. WRN immunoprecipitates were treated or not with lambda phosphatase and subjected to Western blot. Phosphatase treatment converted the slower migrating form of WRN to the faster one, whereas in the untreated samples no noticeable modification was observed (Figure 3a ). In vivo labelling experiments using [ 32 P]orthophosphate showed that immunoprecipitated WRN was radiolabelled after HU or CPT treatment; moreover, phosphatase reversed the radioactive band, clearly demonstrating that WRN was phosphorylated after replication arrest (Figure 3b ). Consistent results were also obtained using antiphosphoserine and antiphosphothreonine antibodies (data not shown).
CPT or UVC could induce DNA damage in the cell cycle phase other than the S phase, resulting in not only replication arrest; thus we analysed WRN phosphorylation in HeLa cells preventively synchronized at G1/S, S or G2 phase, using a standardized double thymidine block protocol (Cao et al., 1991) . WRN phosphorylation, as judged by the appearance of the slower migrating form on Western blots, was observed in treated samples from S phase synchronized cultures (Figure 3c ), but not in either G1-or G2-phase-enriched cells. Similar results were also confirmed using serum starvation as a synchronizing method, suggesting that Sphase-specific phosphorylation following UVC or CPT is ascribed solely to the treatment and not to the synchronization protocol used (data not shown). In addition, a faint WRN smear running at the level of the phosphorylated form was detected in S phase synchronized cells in the absence of any treatment.
We previously reported that WS cells present a higher induction of apoptosis after CPT or HU treatment (Pichierri et al., 2001 ). Since we found WRN similarly modified after CPT, HU and UVC treatment, we wondered whether UVC also were able to induce a higher apoptotic response in WS cells. As expected, WS cells were hypersensitive to CPT-induced apoptotic cell death at all the doses used, whereas UVC treatment resulted in elevated apoptosis only at the higher fluencies (Figure 4 ).
WRN is phosphorylated through both ATR-dependent and -independent mechanisms
Since the key enzyme responsible for the phosphorylation of several proteins involved in the response to agents that interfere with replication is ATR (Shiloh, 2001) , we investigated whether WRN phosphorylation also could be under the control of ATR. We analysed WRN phosphorylation after HU or CPT treatment in cell lines overexpressing the wild-type (ATRwt) or the kinaseinactive form (ATRkd) of ATR (Cliby et al., 1998) . In ATRwt cells, WRN phosphorylation was apparent at both the harvesting times after treatment, whereas in ATRkd cells a band shift, though reduced, was observed only at 8 h. (Figure 5a and data not shown).
Replication fork arrest could cause, directly or indirectly, the formation of double-strand breaks (DSBs) (Bierne and Michel, 1994; Michel et al., 1997; Michel, 2000) ; thus, we verified the possibility that WRN phosphorylation observed in ATRkd cells at 8 h posttreatment could be a response to DSBs. The hypothesis tested was whether ATM kinase, activated by the presence of DSBs, could phosphorylate WRN later than ATR did. For this, WRN phosphorylation after either HU-or CPT-induced replication arrest was analysed in ataxia telangiectasia (AT) cells. Interestingly, in AT cells we found WRN phosphorylated only at 2 and 4 h after treatment ( Figure 5b and data not shown). To confirm this observation, WRN immunoprecipitates from AT or ATRkd cells treated or not with HU were prepared. WRN immunoprecipitates untreated or dephosphorylated with lambda phosphatase were subjected to Western blot analysis using WRN antibodies.
Phosphatase treatment was able to convert the slower migrating form of WRN to the faster one (Figure 5c ), confirming that the band shift observed in AT or ATR was because of WRN phosphorylation. Although WRN has been reported to be phosphorylated by DNA-PK following DNA damage (Yannone et al., 2001; Karmakar et al., 2002) , treatment with doses of wortmannin that selectively inhibits DNA-PK but not ATM/ATR activities did not affect replicationarrest-dependent WRN phosphorylation (Figure 5d ).
WRN protein colocalizes with ATR following replication arrest
Since we found that WRN phosphorylated in an ATR dependent manner after replication arrest, we sought to analyse whether these two proteins could colocalize after replication blockage as reported for ATR and one of its most important substrates, BRCA1 (Tibbetts et al., 2000; Gatei et al., 2001) . (GM3657) and from WS patients (AG14426), normal primary fibroblasts (GM726) and HeLa cells were treated with 2 mm HU or different doses of CPT for 2 h and cell lysates prepared after 4 h of recovery. Alternatively, cells were exposed to UVC as indicated, and lysed 4 h thereafter. Lysates were analysed by PAGE followed by immunoblotting using anti-WRN antibodies. The upper blot was stripped and reprobed using antitubulin antibodies to demonstrate the actual presence of blotted proteins in the lysate from WS cells. (b) Lysates from wild-type lymphoblasts (GM3657) either mock-treated, pulse treated for 2 h with 2 mm HU or CPT, or exposed to UVC were collected at the indicated time points and analysed by Western immunoblotting using WRN polyclonal antibodies. *depicts crossreacting bands. Ponceau red staining of the blots assessed equal loading and transfer
In untreated cells, ATR was found mainly uniformly diffuse in the nucleoplasm, even though B20% of the nuclei demonstrated ATR focal localization (Table 1 and Figure 6 ). ATR focal localization increased after replication arrest in a time-dependent manner starting at 2 h (Table 1) . Also, WRN relocalized in focal structure after replication blockage in a time-dependent manner (Table 1 and Figure 6 ). In contrast with other reports (Marciniak et al., 1998; Constantinou et al., 2000; Orren et al., 2001 ), we did not observe a predominant nucleolar localization of WRN in untreated cells. This should be dependent on either the different antibodies or fixing conditions used in those studies. Using fixing conditions resulting in the elimination of proteins loosely bound to chromatin, we were able to detect a prominent nucleolar WRN localization in untreated cultures, being still able to observe its replication-arrest-dependent relocalization (data not shown). Moreover, Sakamoto et al. (2001) also found WRN evenly distributed in nucleoplasm and nucleoli using fixing conditions similar to those employed in this study.
Significant colocalization of WRN with ATR was noticed starting at 4 h after HU, CPT and UVC treatment, further suggesting the idea of a cooperative action of these two proteins following replication arrest (Table 1, Figure 6 and unpublished observations). On the contrary, under our experimental conditions we were not able to visualize ATM nuclear dots precluding any colocalization analysis (unpublished observations).
WRN subnuclear localization is independent of its phosphorylation
After DNA damage or replication arrest, WRN is able to relocalize in the nucleoplasm (Constantinou et al., 2000; Orren et al., 2001; Sakamoto et al., 2001) . Such a nuclear relocalization is detectable either under normal fixing conditions or under an in situ fractionation method that leaves only the chromatin-bound fraction, suggesting that WRN is tightly associated to chromatin after DNA damage or replication arrest (Franchitto and Pichierri, submitted). Thus, we sought to determine whether WRN subnuclear relocalization could also occur in the absence of its phosphorylation. We analysed WRN redistribution after either HU or CPT in wild-type, ATRkd and AT cells. WRN was able to relocalize correctly either in ATRkd or in AT cells; moreover, a slightly higher percentage of nuclei showing WRN subnuclear redistribution was observed in ATRkd cells (Figure 7a, b) . (GM726) and HeLa cells were treated with 2 mm HU or CPT for 2 h at the indicated dose, or alternatively exposed to different UVC fluencies, washed and harvested after different recovery times to assess the percentage of replicating cells relative to the mock-treated controls. Points represent mean7s.e.m. from at least three experiments; in some cases the error bars are not visible because they are smaller than the symbols In total, 500 mg of total proteins was immunoprecipitated using anti-WRN polyclonal antibodies and incubated either with phosphatase buffer alone (À) or with 300 UI of lambda phosphatase (+) (PPase). Immunoprecipitates were then separated by PAGE and visualized by immunoblotting using a monoclonal antibody against WRN. (b) HeLa cells were starved for phosphate for 30 min, then labelled with [ 32 P]orthophosphate and treated with HU or CPT as described above prior to extraction and immunoprecipitation. The protein levels and phosphorylation were analysed by Western blotting and autoradiography, respectively. Immunoprecipitates were separated on 5% SDS-PAGE gels. Blot membranes were probed with WRN antiserum. When indicated, WRN immunoprecipitates were treated with 300 U of lambda phosphatase prior to SDS-PAGE analysis. (c) Treatment with HU, CPT or UVC induces WRN phosphorylation only in the S phase of the cell cycle. HeLa cells were subjected to a double thymidine block and exposed to 2 mm HU, 50 mm CPT or 40 J/m 2 UVC immediately after the release from the double block (G1/S phase), after 4 h (S phase) or 6.5 h (G2 phase). Lysates were all prepared after 4 h of recovery from the treatment, whereas the untreated samples were processed immediately after the specified postrelease time. In all, 50 mg of total proteins was subjected to PAGE followed by immunoblotting using anti-WRN antibodies. Ponceau red staining of the gel assessed equal loading and transfer. The actual position of the cells at the specific cell cycle stage after synchronization is derived from cytofluorimetric analysis of the DNA content coupled with analysis of the percentage of mitotic cells (mitotic index, M.I.) for the G2-phase enrichment, as already reported (Pichierri et al., 2001) Figure 4 Analysis of apoptotic induction by CPT or UVC treatment. Normal (SNW646 and GM3657) and WS (KO375 and AG14426) lymphoblasts were exposed to different doses of CPT for 1 h or to different fluencies of UVC and harvested after 24 h. The induction of apoptotic nuclei was evaluated by bis-benzimide staining of cells smeared onto microscopic slides as described in Materials and methods. Similar results were obtained by TUNEL assay. Points represent mean7s.e. from at least three experiments
Discussion
Although WS cells show wide genomic instability and hypersensitivity to agents causing DNA damage and in particular interfering with the replication process (Scappaticci et al., 1982; Salk, 1985; Gebhart et al., 1988; Fukuchi et al., 1989; Poot et al., 1999 Poot et al., , 2001 Pichierri et al., 2000b; Bohr et al., 2001 ), the precise role for WRN protein in DNA damage response and replication still remains obscure.
In this paper, we report, for the first time, that the WRN syndrome protein is phosphorylated in response to replication arrest or DNA damage resulting in replication fork stall. Thus, our data include WRN in the group of proteins that are phosphorylated in response to replication arrest, such as BRCA1 (Bierne and Michel, 1994; Scully et al., 1997; Tibbetts et al., 2000) , CHK1 and 2 (Sanchez et al., 1997; Guo et al., 2000; Falck et al., 2001; Zhao and Piwnica-Worms, 2001 ) and RPA (Fotedar and Roberts, 1992; Wang et al., 2001) . We also show that WRN phosphorylation is dependent on both ATR and ATM; ATR is apparently needed to induce the phosphorylation and ATM to maintain the phosphorylated status. After g-rays, a similar kinetic dependence has been described for p53, which is phosphorylated firstly by ATM and then by ATR , and has been envisaged for the NBS1 protein (Zhao et al., 2000) . However, this behaviour after replication arrest is quite novel, since it has been widely established that the main kinase implicated in the response to DNA synthesis blockage is ATR but not ATM (Abraham, 2001) . ATR is specifically involved in the response to all the three agents used in this study (Cliby et al., 1998 (Cliby et al., , 2002 Wright et al., 1998; Guo et al., 2000) , but our data are not necessarily in conflict with such observations. Replication fork arrest generally gives rise to reactions that reestablish a replication fork or require the formation of DSBs at the sites of arrested fork and homologous recombination to restore replication (Michel, 2000; Rothstein et al., 2000; Scully et al., 2000; Michel et al., 2001 ). Thus, it is possible that ATR is involved in WRN phosphorylation as a consequence of abnormal struc- Lysates from cells overexpressing the wild-type (ATRwt) or the kinase-inactive (ATRkd) form of ATR either mock-treated or exposed for 2 h to 2 mm HU or 50 mm CPT and recovered for the indicated time were analysed with PAGE followed by immunoblotting using anti-WRN antibodies. (b) Proteins extracted from wild-type (GM3657) or AT (GM2782) lymphoblasts either mock-treated or exposed for 2 h to 2 mm HU or 50 mm CPT and recovered for the indicated time were analysed with PAGE followed by immunoblotting using anti-WRN antibodies. Similar results were obtained using a second AT lymphoblastoid cell line (GM3189). (c) Lysates prepared from SV-40 transformed AT fibroblasts (GM5849) and cells overexpressing the inactive form of the ATR kinase either mock-treated or exposed for 2 h to 2 mm HU and recovered for the indicated time were immunoprecipitated using anti-WRN antibodies. Immunoprecipitates were incubated either with phosphatase buffer alone (À) or with 300 UI of lambda phosphatase (+) (PPase) and analysed with PAGE followed by immunoblotting using anti-WRN antibodies. Equal loading and transfer were assessed by Ponceau red staining. Similar results were obtained after UVC exposure. (d) HeLa cells were either mock-treated or exposed to 10 mm wortmannin for 30 min before induction of replication arrest by HU or CPT as described above. Lysates prepared at the indicated times were fractionated by SDS-PAGE followed by immunoblotting Figure 6 WRN foci colocalize with ATR after replication arrest. HeLa cells either mock-treated or exposed to 2 mm HU for the indicated time were processed for double immunofluorescent staining with mouse monoclonal anti-WRN and rabbit polyclonal anti-ATR antibodies. Images were handled as described in Materials and methods. Nuclei were considered positive for the colocalization if at least two-thirds of the foci showed a yelloworange appearance in the merged image. Similar results were also obtained after CPT or UVC treatment tures arising at the replication fork, whereas ATM is required later because of the DSBs formation. Consistently with such a hypothesis, ATR-dependent WRN phosphorylation is observed as soon as DNA replication is substantially declined, whereas ATM dependency is evidenced at times corresponding to ongoing recombinational activity, as evidenced by RAD51 focal localization (Pichierri et al., 2001 and unpublished results) . WRN phosphorylation has been reported to be reliable in the presence of an active DNA-PK after g-rayirradiation, bleomycin and 4NQO treatment (Yannone et al., 2001; Karmakar et al., 2002) . However, girradiation, bleomycin and also 4NQO determine DNA breakage and base damage in all the phases of the cell cycle and do not result in the selective and specific demise of the replication fork. Thus, it is likely that WRN may be phosphorylated by DNA-PK in specific cell cycle stages, whereas DNA damage at the replication fork results in the observed ATR/ATMdependent phosphorylation. Despite the reported action of DNA-PK in response to CPT-induced DNA damage (Shao et al., 1999) , we were not able to observe any dependency of WRN phosphorylation to DNA-PK after induced replication arrest using wortmannin at doses at which only DNA-PK is inhibited . WRN has been reported to relocalize in the nuclear volume after different genotoxic treatments, including those resulting in replication arrest (Constantinou et al., 2000; Orren et al., 2001; Sakamoto et al., 2001) . We found that ATR-and ATM-dependent phosphorylation of WRN does not seem to be essential for its subnuclear localization, since it was observed in both AT cells and cell lines expressing an inactive form of ATR. These results are consistent with the reported ability of NBS1 and BRCA1, both modified after genotoxic stress by ATM or ATR, to relocalize in nuclear dots also in the absence of ATM/ATR kinase activity (Gatei et al., 2000; Mirzoeva and Petrini, 2001) . Since WRN phosphorylation is not apparently required for its focal localization after replication arrest, it could be possible that WRN is modified once recruited to the site of replication fork stall as also suggested by colocalization with ATR. At this stage, phosphorylation could serve to activate or inhibit WRN helicase and/or exonuclease activity. Accordingly, DNA-PK phosphorylation of WRN is able to modulate its exonuclease activity negatively (Yannone et al., 2001; Karmakar et al., 2002) . Further studies will be required to specifically address this question.
Recent results suggest that in budding yeast, Sgs1, the yeast homologue of WRN, participates in the checkpoint activated in response to stalled replication forks cooperating with the Mec1 -the yeast ATR homologueand Rad53 kinases (Frei and Gasser, 2000) . According Images were taken after 6 h of recovery but no differences in the appearance of the WRN foci were observed also at the other recovery times at which relocalization was detected to our findings, a similar role for WRN might be envisaged in human cells. We found that WRN focal localization is more elevated in ATR cells, suggesting that the presence of an inactive ATRkd could result in an accumulation of lesions that induce WRN relocalization. It is possible that lack of an active ATR kinase leads to an accumulation of aberrant DNA structures at the stalled replication fork that require the activity of WRN to be resolved. In fact, one of the potential roles for the RecQ class of DNA helicases is to resolve aberrant DNA structures formed during DNA replication (Mohaghegh and Hickson, 2001) . Interestingly, even though we do not observe any WRN modification in untreated asynchronous cultures, a faint band running at the level of the phosphorylated form appeared in mock-treated cells after synchronization in the S phase. Thus, it may be that WRN response is active also during the normal DNA replication; alternatively, it might be possible that synchronization induces per se aberrant structures at the replication fork. The absence of an active WRN leads to enhanced apoptotic cell death after replication perturbation, especially in rapidly growing cells (Poot et al., 1999 (Poot et al., , 2001 Pichierri et al., 2001) and also in untreated cultures (Pichierri et al., 2001) . Enhanced cell death after replication blockage is also a characteristic of ATRkd cells (Cliby et al., 1998; Wright et al., 1998) . ATRkd cells are sensitive to UVC, DNA crosslinking agents, CPT and HU (Cliby et al., 1998) . Also, WS cells are highly sensitive to DNA crosslinkers, CPT, HU (Pichierri et al., 2000a (Pichierri et al., ,b, 2001 Poot et al., 1999 Poot et al., , 2001 and, though to a lesser extent, to UVC (this study). Interestingly, we did not find WS cells sensitive to UVC at the lower doses, consistently with previously reported data (Krepinsky, 1979; Imamura et al., 2002) , whereas elevated apoptosis is clearly detected at the doses used for the phosphorylation studies. Since the highest UVC doses are likely to saturate the excision repair pathway causing massive replication arrest, our data further support the defect in replication arrest recovery (Pichierri et al., 2001) , while confirming excision repair proficiency in these cells (Brosh and Bohr, 2002 and references therein) .
In conclusion, the present study clearly demonstrates that WRN undergoes phosphorylation in an ATR/ ATM-dependent manner specifically after replicative stress and establishes a novel link between WRN and ATR in response to agents that induce replication fork stall, suggesting a possible role of WRN in the S-phase checkpoint response.
Materials and methods

Cell lines
The normal human primary fibroblast GM726, the human normal EBV-transformed lymphoblast cell line GM3657 and GM5849, SV-40 transformed fibroblasts derived from an AT patient, were all from Coriell Cell Repositories (Camden, NJ, USA). GM02782 and GM03189 were two EBV-transformed AT lymphoblastoid cell lines. The SV-40 transformed fibroblast cell line conditionally overexpressing the kinase-dead form of ATR kinase (ATRkd) has been described elsewhere (Cliby et al., 1998) . The normal human primary fibroblasts were cultured in DMEM medium (Life Technologies) supplemented with 15% heat-inactived foetal calf serum and 2 Â of nonessential and essential amino acids (Life Technologies). All lymphoblastoid cell lines were routinely maintained in exponential growth in RPMI 1640 medium (Life Technologies) supplemented with 12% heat-inactived foetal calf serum (Boehringer Mannheim) by a daily dilution to 3.5 Â 10 5 cells/ ml. All other cell lines were maintained in DMEM medium (Life Technologies) supplemented with 15% foetal calf serum. The SV-40 transformed ATRkd cells were grown in DMEM medium (Life Technologies) supplemented with 15% foetal calf serum (Hyclone) in the presence of 400 mg/ml of G418 (Sigma). When needed, expression of the transgene was achieved by the addition of 1 mm doxycycline (Sigma) for 72 h.
Chemicals and treatments
HU (Sigma) was added to the cultures from a 200 mm stock solution and either left until harvesting or washed out after 2 h. Alternatively, CPT (Sigma) was added from a 100 mm stock solution to give the indicated doses and removed after 2 h with extensive washing. For UVC irradiation, cells were washed with PBS and then irradiated at the indicated doses with a UV lamp (254 nm, Philips). After treatments, cells were cultured in complete medium at 371C until being processed. When needed, expressions of the inactive form of ATR were maintained by recovering cells in the continuous presence of 1 mm doxycycline.
Recovery of DNA synthesis after treatment
In order to verify the arrest of DNA synthesis after treatments, cells were exposed to CPT, HU or UVC, and harvested in drug-free medium for different time points. BrdUrd (30 mg/ml) was added 1 h before harvesting and BrdUrd incorporation was evaluated as previously described (Pichierri et al., 2001) . At least 500 interphase cells were scored to evaluate the percentage of labelled nuclei. Only nuclei displaying a more or less uniform BrdUrd labelling in the entire volume were considered as actively replicating. The percentage of cells undergoing DNA synthesis at each time point was calculated as a fraction of the treated cells versus untreated controls.
Evaluation of the apoptotic response
Apoptotic morphology was determined as previously described (Pichierri et al., 2001) . Apoptosis was also visualized using the TdT-mediated end-labelling (TUNEL) assay using the In Situ Cell Death Detection Kit (Roche Molecular Biochemicals) according to the procedure indicated by the manufacturer for analysis on slides. Results obtained with the two different methods were similar.
Immunoprecipitation and Western blot analysis
Cells (1 Â 10 7 ) were collected by low-speed centrifugation, washed in PBS and lysed in standard RIPA buffer (PBS, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, 10 mg/ml aprotinin, 10 mg/ml PMSF, 2 mm b-glycerophosphate, 1 mm Na orthovanadate, 1 mm NaF). Cell lysates (40 mg) were loaded on 3-8% polyacrylamide Tris-acetate gels (NuPage, Novex), resolved at 180 V for 2 h and then transferred to nitrocellulose (PROTRAN, Schleicher and Schuell) by a semidray apparatus (Bio-Rad). Equal loading and transfer was monitored by Ponceau red staining of the membrane. Blots were incubated (overnight at 41C) with rabbit polyclonal antibodies against WRN (Novus Biochemicals, 1 : 4000).
Horseradish peroxidase-conjugated goat specie-specific secondary antibodies (Santa Cruz Biotechnology) were used at a dilution of 1 : 1000 and visualization of the signal was accomplished using ECL plus (Amersham).
In immunoprecipitation experiments, cells (1.5 Â 10 7 ) were lysed in a mild lysis buffer (50 mm Tris/HCI pH 8, 300 mm NaCI, 10 mm MgCI 2 , 1 mm EDTA, 25 mm b-glycerophosphate, 0.5% lgepal-40), including protease and phosphatase inhibitors (10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml PMSF, 1 mm Na orthovanadate, 1 mm NaF). In total, 500 mg of lysate was precleared with Sepharose-protein A/G beads and then incubated overnight at 41C with anti-WRN antibodies and Sepharose-protein A/G beads. After extensive washing in mild lysis buffer, WRN-containing immunoprecipitates were boiled in electrophoresis sample buffer and analysed by immunoblotting. For phosphatase treatments, immunoprecipitates were resuspended in phosphatase buffer and incubated for 30 min with 300 units of lambda phosphatase (New England BioLabs) at 301C and then boiled in electrophoresis sample buffer prior to Western blotting analysis.
P in vivo labelling
In vivo labelling experiments used exponentially growing HeLa cells. The cells were washed with phosphate-free DMEM medium, supplemented with 10% heat-inactivated foetal calf serum, and incubated for 30 min at 371C in the same media. [ 32 P]orthophosphate (Amersham) was added directly to the medium (0.6 mCi/ml). After 30 min incubation at 371C, cells were either mock-treated or exposed to 2 mm HU for different time periods. The cells were lysed as described above and WRN immunoprecipitated using 3 ml rabbit anti-WRN antiserum (AbCam Ltd). The immunoprecipitated proteins were resolved by SDS-PAGE, analysed by autoradiography and Western blotting.
Immunofluorescence
Cells cultured on coverslips were treated or not with HU (2 mm), CPT (50 mm) or UVC (20 J/m 2 ), harvested after 4 h of recovery and fixed as previously described (Pichierri et al., 2001) . Briefly, cells were fixed in 4% paraformaldehydebuffered solution for 30 min at 41C and then permeabilized using a 0.5% Triton X-100 solution. For WRN/ATR double immunostaining, cells were fixed in ice-cold 50 : 50 acetone : methanol, allowed to reach room temperature before air drying, then rehydrated with PBS and blocked for 1 h in 10% FBS/PBS. Staining with rabbit polyclonal anti-WRN (AbCam Ltd), mouse monoclonal anti-WRN (Pharmingen), rabbit polyclonal anti-ATR (Oncogene Research) was performed overnight at 41C in PBS/1% BSA, whereas specie-specific fluorescein-or Texas Red-conjugated secondary antibodies (Jackson Immunoresearch) was applied for 1 h at RT, followed by counterstaining for 5 min at RT with 0.5 mg/ml DAPI. All the primary antibodies were used at a 1 : 300 dilution, whereas the secondary antibodies were employed at a 1 : 500 dilution. Slides were mounted in Vectashield (Vector Labs) and analysed by a Leica epifluorescence microscope equipped with a CCD camera. Images were acquired as grey-scale files using the Metaview software, then pseudocoloured, processed and merged using Adobe Photoshop. For each time point, at least 200 nuclei were examined and WRN or ATR foci scored at a Â 100 magnification. Only nuclei showing >10 foci were considered as positive. Parallel samples, incubated either with the appropriate normal serum or only with the secondary antibody, confirmed that the observed fluorescence pattern was not attributable to artefacts.
